AUG 17, 2026 · PHASE 1/2 TRIAL
HS235 Study in Obese Participants With Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction (HFpEF)
ClinicalTrials.gov
This is a Phase 1/2 trial registration with no posted results; it is early-stage work in a novel biologic for a rare comorbid phenotype.
Reported
Estimated enrollment126
PhasePhase 1/2
Primary outcome measureIncidence and Number of Adverse Events, up…